Lantern, founded in 2010 and headquartered in Dallas, Texas, is a specialty care access platform focused on connecting patients with top-performing specialists for surgery, cancer, and infusion therapies. The company has raised a total of $2.5 million in funding, including $1.5 million (Series B, 2011) and $1 million (Series A, 2010), with a Series C round in 2016 led by Dundon Capital Partners. Backed by Texo Ventures, Lantern employs 51–200 professionals and continues to expand its technology-driven platform to improve access, outcomes, and affordability in complex healthcare.